Avvinity was established as a Joint Venture between Horizon Discovery and Centauri Therapeutics therefore the leadership team consists of four Directors representing both organizations.
Dr. Darrin Disley
Darrin is a parallel entrepreneur, angel investor and enterprise champion. He has been involved in the start-up and growth of numerous business ventures securing over $320 million business financing from grant, angel, corporate, venture capital and public market sources as well as closing over $500 million of product, service, licensing and M&A deals.
Darrin holds a PhD in Biotechnology from the University of Cambridge has been the author of numerous papers, patents and conference abstracts and has been an advisor on biotech commercialisation strategies around the world.
Chief Executive Officer, Centauri Therapeutics
Mike has 15 years' experience in Pharma R&D, having worked for both Roche and Pfizer. Mike has worked across the Research and Development spectrum and whilst at Pfizer he helped successfully develop a novel therapy for treatment of HIV infection. Mike also headed up Pfizer's Opportunities for Partnership in Medicine (OPM) Research Unit and was a member of the Research Our Leadership Team at Pfizer's R&D UK Laboratories. Mike trained in Molecular Biology and Biochemistry at University of Durham, obtained his PhD at Warwick University and then completed a postdoctoral research fellow at St George's Hospital Medical School.
Chief Scientific Officer, Horizon Discovery
Jon spent 10 years at Vernalis culminating in a role as Head of Biology, where he was responsible for both cell biology and assay development activities. He also led the biology side of several innovative drug discovery programmes and managed a major research alliance with GSK. Jon’s research interests include cancer metabolism, signal transduction and, prior to making the move to industry, he gained extensive postdoctoral experience in the cell cycle control field working with first Sally Kornbluth at Duke and then Nobel Prize winner, Tim Hunt, at Cancer Research UK’s Clare Hall labs. He holds a PhD from the University of Newcastle upon Tyne and is a Fellow of the Society of Biology.
Business Development Advisor, Centauri Therapeutics
Nick is a Director of Lizard BioConsulting, an independent consultancy specializing in business development for life science companies, which he founded in March 2013. He is also a non-executive director and Deputy Chairman of the Cell and Gene Therapy Catapult. From 2010 he was Corporate Development Director of Consort Medical plc, a healthcare company focused on medical device technologies for drug delivery.
From 2005 until 2010 he was Chief Executive of Intercytex Group plc, a regenerative medicine company. Prior to that he was Chief Business Officer of Acambis, a leading producer of vaccines to treat and prevent infectious disease, until 2005.
© 2017 Horizon Discovery. All Rights Reserved